|
Market Closed -
Nasdaq
00:00:00 25/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.190 USD | -1.87% |
|
-0.95% | +24.33% |
| 08-06 | Ironwood Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Ironwood Pharmaceuticals, Inc. Raises Earnings Guidance for the Year 2026 | CI |
Company Valuation: Ironwood Pharmaceuticals, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,908 | 1,901 | 1,786 | 708.9 | 548.2 | 692.4 | - | - |
| Change | - | -0.4% | -6.02% | -60.31% | -22.67% | 26.29% | - | - |
| Enterprise Value (EV) | 1,742 | 1,641 | 1,786 | 708.9 | 548.2 | 692.4 | 692.4 | 692.4 |
| Change | - | -5.83% | 8.87% | -60.31% | -22.67% | 26.29% | 0% | 0% |
| P/E | 3.63x | 12.9x | -1.77x | 443x | 22.5x | 3.43x | 3.18x | 2.93x |
| PBR | 3.12x | 3.54x | - | - | - | - | - | - |
| PEG | - | -0.2x | 0x | -4x | 0x | 0x | 0.42x | 0.34x |
| Capitalization / Revenue | 4.61x | 4.63x | 4.03x | 2.02x | 1.85x | 1.47x | 1.4x | 1.38x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.47x | 1.4x | 1.38x |
| EV / EBITDA | 0x | 0x | -0x | 0x | 0x | 2.07x | 2.02x | 1.93x |
| EV / EBIT | 0x | 0x | -0x | 0x | 0x | 2.19x | 2.25x | 2.19x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 3.31x | 2.58x | 2.49x |
| FCF Yield | 13.7% | 14.4% | 10.3% | 14.6% | 23.2% | 30.2% | 38.8% | 40.2% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 3.21 | 0.96 | -6.45 | 0.01 | 0.15 | 1.223 | 1.317 | 1.43 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 413.8 | 410.6 | 442.7 | 351.4 | 296.2 | 471.4 | 494 | 500.5 |
| EBITDA 1 | 233.7 | 251.8 | -884.8 | 100.6 | 138.1 | 334.2 | 343.4 | 358.8 |
| EBIT 1 | 232.2 | 250.3 | -945.4 | 94.85 | 98.5 | 316.8 | 307.6 | 315.5 |
| Net income 1 | 528.4 | 175.1 | -1,002 | 1.813 | 24.02 | 203.3 | 219.9 | 240.7 |
| Net Debt | -165.9 | -260 | - | - | - | - | - | - |
| Reference price 2 | 11.660 | 12.390 | 11.440 | 4.430 | 3.370 | 4.190 | 4.190 | 4.190 |
| Nbr of stocks (in thousands) | 163,650 | 153,395 | 156,129 | 160,028 | 162,679 | 165,240 | - | - |
| Announcement Date | 17/02/22 | 16/02/23 | 15/02/24 | 27/02/25 | 25/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 3.43x | - | - | - | 692M | |
| 107.66x | 6x | 25.47x | 2.31% | 365B | |
| 22.68x | 3.07x | 10.73x | 1.75% | 66.21B | |
| 15.99x | 7.78x | 11.93x | - | 13.08B | |
| 14.43x | 1.8x | 6.11x | 3.07% | 7.45B | |
| 17.92x | 5.57x | 14.88x | -.--% | 4.34B | |
| 35.37x | 2.32x | 26.43x | 0.78% | 4.04B | |
| 34.7x | 5.43x | 15.9x | - | 3.02B | |
| -216.45x | - | - | -.--% | 2.52B | |
| Average | 3.97x | 4.57x | 15.92x | 1.32% | 51.83B | |
| Weighted average by Cap. | 87.70x | 5.53x | 22.51x | 2.19% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IRWD Stock
- Valuation Ironwood Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
